Share Name Share Symbol Market Type Share ISIN Share Description
IQE Plc LSE:IQE London Ordinary Share GB0009619924 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.25p -3.97% 30.25p 30.25p 30.50p 31.50p 30.25p 30.25p 3,401,925 16:26:48
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Technology Hardware & Equipment 114.0 19.4 3.0 10.1 203.39

IQE (IQE) Latest News

More IQE News
IQE Takeover Rumours

IQE (IQE) Share Charts

1 Year IQE Chart

1 Year IQE Chart

1 Month IQE Chart

1 Month IQE Chart

Intraday IQE Chart

Intraday IQE Chart

IQE (IQE) Discussions and Chat

IQE (IQE) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
17:25:0630.44100,00030,440.10O
17:24:3030.30100,00030,302.30O
17:06:2330.97181,05656,066.71O
16:54:0831.0517,3415,384.52O
16:53:4131.1630,0009,347.16O
View all IQE trades in real-time

IQE (IQE) Top Chat Posts

DateSubject
26/9/2016
09:20
IQE Daily Update: IQE Plc is listed in the Technology Hardware & Equipment sector of the London Stock Exchange with ticker IQE. The last closing price for IQE was 31.50p.
IQE Plc has a 4 week average price of 28.03p and a 12 week average price of 24.65p.
The 1 year high share price is 32.25p while the 1 year low share price is currently 16p.
There are currently 672,352,147 shares in issue and the average daily traded volume is 6,329,537 shares. The market capitalisation of IQE Plc is £203,386,524.47.
22/9/2016
11:03
rivaldo: Tipped in today's Shares Mag FYI: "IQE sees the light Rapid growth in Photonics to keep re-rating going CITY ANALYSTS ARE growing increasingly confident about the growth prospects of compound wafer designer IQE (IQE:AIM), with number crunchers at N+1 Singer hiking their target price for the shares by more than 20% to 35p. A return to growth on its biggest Wireless business is one reason. Half year revenue here increased 7% to £43.2 million thanks to market share gains and investment in 4G and 5G mobile networks and handsets, which typically require a greater proportion of compound silicon wafer technology. But the real kicker comes from the Cardiff-based company’s higher-value Photonics side. This feeds laser technology into several applications, such as data centre connectivity, sensing applications, healthcare, cosmetic treatments, industrial illumination, heating and fibre to premises. IQE’s wafers for Photonics applications are more rich in intellectual property (IP) than Wireless applications, meaning that IQE is becoming a more influential part of the supply chain in more profitable markets. In the first half Photonics revenues soared 45% to £10.7 million delivering adjusted operating profit of £2.73 million, or 25.5% operating margins. That compares to 11.8% margins in the Wireless unit. ‘Process improvements over the past few years have meant that the performance and cost points necessary for mass adoption are now being met, which we feel will drive sustained growth going forwards,’ says N+1 Singer analyst Oliver Kno. SHARES SAYS: 􀁓􀁔 At 30.25p the stock trades on a price to earnings (PE) multiple of 10.8-times, falling to 10.1 next year. That looks too deeply discounted in spite of the strong recent share price run. A 40p share price would still imply a 2017 PE of only 13.3."
20/9/2016
18:45
big7ime: We have a Firm Breakout which looks good to the next historic resistance at 36p. The p/e is still under 10 and with the growth in photonics, GAN,power switching All to come the share price has to re-rate which is under way. Personally I'd have thought a p/e of 30 is not unreasonable given the growth rates which would treble the price. Before those shoot me down claiming this is IQE, there are many examples of companies with poor "PR" those dogs whose share price struggles where sentiment virtually overnight turns to become the darlings of the index and then go on to overshoot the other way being much too optimistic in the valuation. I thought it would happen before now, the turnaround as it's been a dog for a few years for misconstrued worries but the concerns have been put to bed and the board have been proved right. For now I will settle for p/e of 15 which gives this much upside, and obviously it won't be a straight line but the chart is looking a lot healthier so we have reason to be cheery chaps...
14/9/2016
23:19
strathroyal: I know that there is a great deal of frustration at the share price of IQE and it probably should be higher than it is but, having said that, I don't understand why so many on here expected it to rise on the results. The recent Trading Update had trailed the H1 figures and the share had risen accordingly, so why would they go again? That particularly unlikely as no attempt was made to talk up H2. As we all buy shares for future performance rather than past results, this was always likely to temper the share price. I remain very sceptical about the Intangibles which were increased by £9M this time. Whilst they are a non cash item, they nevertheless impact upon the true gearing level and now account for £96m of the £172M shareholder funds. IQE remains a small company and, whilst CMOS may shortly/eventually be a growth area, I think that there is more than a possibility that they are going to end up as a jack of all trades. Finally, American Idiot, I can't believe you bought at 28.75. Having read your debate with Sweenoid over trading these shares rather than holding, I decided yours was the correct strategy and sold out yesterday. I would have thought you would have been selling down to, say, 23p not buying at these inflated levels. If I may ask, why have you changed horses?
18/7/2016
14:45
loobrush: I have a fair holding in IQE and can't quite understand why they have such a low rating. Obviously the market in general does not as yet have a positive view of its potential. Hopefully the update shortly will be a positive update and if good news keeps coming IQE could rerate very quickly indeed. I am of the view that IQE is on track to be a substantial businees within a couple of years and think that the share price should at least be at last years high of 27p by xmas if update ok. That is unless it recieves a bid before then,if that is the case the share price would be anyones guess. So all in all its a higher share price on a bid or good news -for me.
02/11/2015
10:42
fullbright: IQE plc 38.6% Potential Upside Indicated by Canaccord Genuity Posted by: Ruth Bannister 28th October 2015 IQE plc using EPIC/TICKER code LON:IQE has had its stock rating noted as ‘Reiterates217; with the recommendation being set at ‘BUY’ today by analysts at Canaccord Genuity. IQE plc are listed in the Technology sector within AIM. Canaccord Genuity have set their target price at 35 GBX on its stock. This would imply the analyst believes there is now a potential upside of 38.6% from the opening price of 25.25 GBX. Over the last 30 and 90 trading days the company share price has increased 0.5 points and increased 3 points respectively. IQE plc LON:IQE has a 50 day moving average of 25.20 GBX and a 200 Day Moving Average share price is recorded at 23.43 GBX. The 52 week high for the share price is currently at 27 GBX while the 52 week low is 15.25 GBX. IQE plc is a United Kingdom-based holding company. The Company is engaged in the research, development and provision of engineering consultancy services to the compound semiconductor industry. It is engaged in the sale of advanced semiconductor materials. Its operating segments are wireless, photonics and electronics. Its finished products are compound semiconductor wafers. It operates in the United States, Asia and Europe. hxxp://www.directorstalkinterviews.com/iqe-plc-38-6-potential-upside-indicated-by-canaccord-genuity/412682131
23/10/2015
17:10
yump: I'm curious as to why IQE share price is so active. I don't mean the major ups and downs, I mean the constant 10% oscillations. Other companies of the same size often seem relatively stable. They'll sit roughly at the same level for months without the ADHD stuff.
14/11/2014
20:26
sweet karolina: Also worth a read: HTTP://www.shareprophets.com/views/8961/iqe-plc-some-additional-detail-on-transaction-with-equities-first-provided-but-significant-questions-still-to-be-answered Having on Wednesday written on the recent dealings of IQE plc (IQE) directors with Equities First Holding LLC and on the same day contacted both the company and its Nomad, Canaccord Genuity, emphasising that further information should be provided and pointing to the questions my article raised, I have had no direct response from either, but note a 12:53pm Thursday announcement “to provide… further information”. The following reviews. Firstly, having stated in its initial announcement that “the directors have entered into loan agreements and have transferred a total of 18 million existing shares as security”, it is now stated that “Dr Drew Nelson entered into a share sale and repurchase agreement with Equities First Holdings on 10th October 2014 for a total of 18 million existing shares, raising a total of £1.865 million before commissions of £55,944… As part of this overall arrangement, Phillip Rasmussen and Dr Howard Williams have agreed to enter into separate loan agreements with Dr Nelson by pledging 2.72 million shares each to Dr Drew Nelson as security for loans provided by him of £274,000 to each of them”. So “loan agreements” is now “a share sale and repurchase agreement” and the 18 million shares aren’t from “the directors” but solely Drew Nelson. This leads on to the specific questions I raised in my previous article (questions in bold, company response from its announcement in italics)... Does the cash received from Equities First exactly match the announced share purchases + the income tax obligations following the announced share options exercise? “Approximately 52% of the monies raised by the Executive Directors have already been used to fund the purchase of the shares and to satisfy income tax and NI obligations following the exercise of share options announced on 10th October... The remainder of the monies raised is intended to be used to fund further tax liabilities and NI due on the exercise of share options which are due to vest in early 2015, as well as fund further share purchases and cover any potential margin calls under the share sale and repurchase agreement. The share option exercises were part of IQE's LTIP, and the directors were under no time obligation to exercise such share options, but chose to do so at this time in order to maximise their respective shareholdings in the company.” Equities First state that “in the event of substantial decline in market value, clients can simply walk away from the loan with no additional expense because it is a non-recourse loan”, how does this tally with IQE’s “Directors are required to redeem the transferred shares at maturity when the loan is repaid at the end of the three year term”? “He is obligated to repurchase all these shares at the end of a three year term, ending on 10th October 2017”. “Under the terms of the facility, the lender is prohibited from short selling or voting the shares during the term of the loan”, what about ‘the lender’ simply selling the shares? “The agreement provides that he has transferred all title and waives his voting rights in these shares. However, as previously stated, under the terms of the agreement, EFH is prohibited from short selling or voting the shares during the term of the agreement”. “Following these purchases, the executive directors have the following interests in the equity of the company”, do they? – what about the 18 million shares “transferred”? The company publishes a table which shows shareholdings unchanged from its previous announcement though with asterisks added that “These include the 18 million shares that Dr Drew Nelson sold but retains the obligation to repurchase” and that “In aggregate, using the share and repurchase agreement and associated inter-director loans, the directors have increased their interests in the companys shares by a total of 11,841,823 shares or 38%”. That “EFH is prohibited from short selling or voting the shares during the term of the agreement” is thus likely irrelevant as it has the ability to simply sell the shares (“the agreement provides that he has transferred all title”). Indeed, together with Nelson having waived his voting rights in these shares, it doesn’t seem right to include them in stated director shareholdings – particularly with there no further clarity provided on his “obligation to repurchase” against Equities First’s “non-recourse” statement. Additionally, shares in IQE currently trade at 17p and, with it stated that “the price at which he is required to repurchase the shares is 11.4 pence per share”, this sparks thoughts of counterparty risk and other questions remain including; •The announcement notes “potential margin calls under the share sale and repurchase agreement”, what are the details of these (cloudBuy plc, for example, has provided not enough detail but some)? ; •My unanswered second question; how does the “obligation to repurchase” tally with Equities First’s “non-recourse” statement? ; •Is there any comment on the IQE share price, which from closing at 16.5p on 6th October 2014, fell to 15.25p (7th October), 13.25p (8th October), 12.75p (9th October) and 12.5p (13th October) on no announcements from the company from 17th September 2014 until 10th October 2014 (directors exercise of share options)? I’ll again be sending this to the company and Canaccord.
10/9/2014
11:16
gumberr: HOME » LSE » LSE » IQE share price IQE PLC Iqe Plc : Notice Of Results Print Alert TIDMIQE IQE plc Notice of interim results Cardiff, UK - 10 September 2014: IQE plc (AIM: IQE), the leading global supplier of advanced semiconductor wafer products and wafer services to the semiconductor industry, will be publishing its results for the half year ended 30 June 2014 on Tuesday, 16 September 2014. Drew Nelson, Chief Executive Officer, and Phil Rasmussen, Finance Director, will present the results to analysts at 9.30am on Tuesday, 16 September 2014 at the offices of Broker Profile, Augustine House, 6A Austin Friars,
23/7/2014
13:40
hannath: To say that IQE (IQE: 20.25p), a leading global supplier of advanced wafer products and wafer services to the semiconductor industry, has proved a frustrating holding would be the understatement of the year. The share price action since the start of this year has been punctuated by sharp share price rallies, but ones that never hold. In fact, until this week the share price was little changed on when I updated the investment case ('Wafer maker sell-off overdone', 4 February 2014), and a few months later ('Time to chip in again', 17 April 2014). However, a trading update ahead of first half results on 16 September sent the shares down 12 per cent from 23p to 20.5p, and means that they are now sitting on the support level dating back to early February. The main reason for the latest lurch downwards is news that the company's first half revenues have fallen 17 per cent to £52m, impacted as expected by destocking among major wireless customers due to weakness in the handset market at the end of last year and which continued into the start of 2014. The strength of sterling has proved a headwind too as this had an adverse effect on translation of revenues. In constant currency terms, sales were down 10 per cent. The good news is that despite these headwinds, IQE's cash profits are up 5 per cent to £11m in the first six months of 2014 and with the benefit of cost savings, a change in the sales mix to higher margin products, and synergy benefits from acquisitions, the company is still on course to achieve analysts full-year earnings expectations. Analysts Dan Ridsdale and Tom Grady at Edison Investment Research expect IQE to drive up adjusted pre-tax profits from £13m to £14.9m this year and to boost adjusted EPS by 10 per cent to 2.2p. Analysts at broking house N+1 Singer are looking for pre-tax profits of around £14m and EPS of 2.1p this year. On this basis, IQE's shares trade on a modest 9 times current year forward earnings, around half the rating of rival Visual Photonics Epitaxy and wireless customers RF Micro Devices. It is also reassuring to note that customer order levels have improved in recent months and the company is "seeing positive customer forecasts for the rest of the year." This primarily reflects the acceleration of TD-LTE smartphone adoption in China, new handset launches, and the increasing adoption of new dual band wifi. To recap, IQE uses advanced crystal growth technology to manufacture and supply bespoke semiconductor wafers to major chip manufacturers, who then use them to make the chips that form the key components of virtually all high-technology systems. The company also manufactures advanced optoelectronic and photonic components such as semiconductor lasers and optical sensors for a range of applications, including: DVD and Blu-ray storage; thermal imaging; ultra-high-brightness LEDs; and high-efficiency concentrator photovoltaic (CPV) solar cells. IQE has exposure to this market through a venture with Solar Junction, a leading CPV developer and manufacturer. Targeting growth markets It is comforting to note too that IQE's photonics business is performing strongly and the company expects to report 20 per cent revenue growth in the year to date, reflecting the move into high volume production and supported by a number of contract wins. For instance, only last month IQE announced a multi-year contract win worth in excess of £1m per year in additional revenues for its photonics business unit. The win is with an existing customer with a significant presence in the Asia-Pacific region, where photonics markets are predicted to experience rapid growth. IQE will manage the customer's inventory as it does for a number of others, allowing it to manage short-term fluctuations in demand. Analysts at broking house N+1 Singer were predicting 10 per cent growth in the photonics business this year, pencilling in revenues of £20.5m. Following today's pre-close trading update, this now looks on the low side, highlighting the growth potential from this specific market. It also highlights how IQE is moving its reliance away from traditional wireless markets (which accounted for 85 per cent of last year's sales) which are susceptible to greater fluctuations in short-term demand from customers. The outlook for IQE's high-efficiency concentrator photovoltaic (CPV) solar cells business is equally promising. IQE has exposure to this market through a venture with Solar Junction, a leading CPV developer and manufacturer. Expect a move into production in the second half this year. So, despite the revenue shortfall, chief executive Drew Nelson remains positive, and with good reason. He notes that: "In terms of trading, all our lead indicators are pointing in the right direction. The destocking was concluded during the second quarter and customers are forecasting an upbeat second half. Our investment in photonics technology is delivering tangible benefits, and has resulted in multiple contract wins. " It's worth pointing out too that IQE's net debt has been cut by £1.5m to £36m this year even after factoring in restructuring cash costs of £3m and £2m of inventory build. These items mainly relate to the acquisition of Kopin, a company purchased by IQE 18 months ago and one which has significantly extended IQE's market share and leadership in wireless industry supply; added Skyworks Solutions, which has a long-standing supply agreement with Kopin Wireless, to the customer base; and brought in a Taiwanese manufacturing facility to boost IQE's global manufacturing footprint. It has also positioned the business to access the growing Asian semiconductor market. The acquisition still looks a sensible deal in my view and analysts expect IQE's net debt to be cut by a further £4m to £32m by the year-end, reflecting the company's cash generation. Investment case still intact That said, clearly investors are disappointed by the revenue miss even though profits are still expected to be in line with analysts' forecasts. The sales shortfall is also detracting from the medium-term industry dynamics which underpin IQE's business model. These include the global roll-out of 4G and LTE, the evolution of WiFi, new wireless devices including wearable technology, and the incorporation of sensors and laser projection, which are largely enabled by compound semiconductor photonics technology. Furthermore, smartphone shipments are forecast to continue to grow in the coming years driven by new features, apps, social networking, entertainment and location based services. To put this in perspective, 1.8bn mobile handsets were sold globally in 2013, of which more than 1bn were smartphones that carry significantly more compound semiconductor materials. US market research company IDC predict smartphone shipments will hit 1.7bn handsets by 2017. It's also worth pointing out that high-speed connectivity will drive the requirement for the advanced properties offered by compound semiconductor epiwafers. The global roll-out of wireless broadband networks such as 4G/LTE devices increasingly rely on higher levels of compound semiconductor content with 5G expected to demand a quantum leap in speed, power and efficiency. And the migration to new higher frequency WiFi standards is another major driver for radio frequency (RF) components and is expected to boost demand for compound semiconductor based RF devices. So, although IQE's share price is weak, and sentiment is poor, I still feel the company is very undervalued even though a drift to the next support level around 18p can't be ruled out. This coincides with the support level from June last year and also at the end of 2011. I would expect a strong bounce if this is ever tested. To kick start the share price, analyst Lorne Daniel at broking house finnCap believes the "key to an improvement will be cash flow generation and reduction of debt". I would agree and believe that with a better second half performance on the cards, there is more upside potential than downside risk at this point. My fair value target price of 35p may seem miles away with the shares trading on a bid-offer spread of 20p to 20.25p, but I would still be using the current share price weakness as a buying opportunity, albeit IQE is one of the most frustrating companies I have ever covered.
24/4/2014
17:05
gumberr: Apple turning over the IQE share price! Long live the iphone!
IQE share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20160926 22:30:19